Extra reports that model and body positive activist Elly Mayday has passed away at the age of 30. Mayday died on Friday, March 1st, following a long struggle with ovarian cancer. Mayday was diagnosed..
According to a report by Reuters, on Wednesday, a key supplier of talc used in Johnson & Johnson's baby powder filed for Chapter 11 bankruptcy in the wake of multibillion-dollar lawsuits alleging its..
U.S. drug developer ImmunoGen Inc said on Friday its experimental ovarian cancer drug failed to meet the main goal of a late-stage study, driving its shares more than 40 percent lower on Friday. Reuters - Published
A key supplier of talc used in Johnson & Johnson's baby powder filed for Chapter 11 bankruptcy on Wednesday in the wake of multibillion-dollar lawsuits alleging its products caused ovarian cancer and.. Reuters - Published
Johnson & Johnson failed to persuade a Missouri trial judge to set aside a verdict awarding a record $4.69 billion to 22 women who blamed their ovarian cancer on asbestos in the company's Baby Powder.. Reuters - Published
Healthcare conglomerate Johnson & Johnson has lost its motion to reverse a verdict that awarded $4.7 billion to women who blamed ovarian cancer on asbestos in the company's Baby Powder and other talc.. Reuters - Published
Thousands of NHS patients with a genetic type of ovarian cancer will soon have access to a new treatment, hailed as a wonder drug, that slashes the risk of death from the condition by 70 per cent. MailOnline - Published
Nice has ruled against expanding the use of groundbreaking drug olaparib, developed by British scientists. Charity cancers call it a 'bitter blow' to thousands who could miss out. MailOnline - Published
The actress, who played a doctor on Grey's Anatomy, went off-script on The Ellen Show this week, to tell viewers that she'd heard 'all it takes is a simple ultrasound' to detect the disease. MailOnline - Published
An AstraZeneca drug that blocks a cancer cell's ability to repair its genetic code greatly reduced the risk of ovarian cancer worsening in a phase III trial, underpinning its lead against two U.S... Reuters - Published